Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Little Green PharmaASX:LGP -1.32% EV-to-OCF is 1,676.18 as of Aug. 08, 2026. The stock has 3 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Little Green Pharma ranks worse than 99.4% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Little Green Pharma's Enterprise Value is A$65.37 Mil.
Little Green Pharma's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was A$0.04 Mil. Therefore, Little Green Pharma's EV-to-OCF for today is 1,676.18.
The historical rank and industry rank for Little Green Pharma's EV-to-OCF or its related term are showing as below:
ASX:LGP'
s EV-to-OCF Range Over the Past 10 Years
Min: -48.64 Med: -5.95 Max: 1676.18
Current: 1676.18
During the past 7 years, the highest EV-to-OCF of Little Green Pharma was 1676.18. The lowest was -48.64. And the median was -5.95.
ASX:LGP's EV-to-OCF is ranked worse than 99.4% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 10.87
vs ASX:LGP: 1676.18
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Little Green Pharma (ASX:LGP) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Little Green Pharma's PE Ratio (TTM) for today is calculated as:
Little Green Pharma's share price for today is A$0.075.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Little Green Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was A$-0.005.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Little Green Pharma EV-to-OCF Related Terms
Little Green Pharma EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Little Green Pharma's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Little Green Pharma EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Little Green Pharma's EV-to-OCF falls into.
Little Green Pharma's current Enterprise Value is A$65.37 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Little Green Pharma's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was A$0.04 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Little Green Pharma (ASX:LGP) has a EV-to-OCF of 1,676.18 as of Aug. 08, 2026. According to the industry distribution chart, Little Green Pharma ranks #1001 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 99.4%.
Is Little Green Pharma's EV-to-OCF too high?
Little Green Pharma's current EV-to-OCF is 1,676.18. The Drug Manufacturers industry median EV-to-OCF is 10.87. Little Green Pharma's value of 1,676.18 is 15320.2% above this industry median. Based on the distribution chart, Little Green Pharma ranks #1001 out of 1007 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Little Green Pharma's EV-to-OCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Little Green Pharma ranks #1001 out of 1007 companies for EV-to-OCF. This places Little Green Pharma in the lower half of its industry. The industry median EV-to-OCF is 10.87. Little Green Pharma's value of 1,676.18 is 15320.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.87, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Little Green Pharma's current EV-to-OCF of 1,676.18 is 15320.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Little Green Pharma's current EV-to-OCF is 1,676.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.18, compared to a current price of A$0.08 — trading 58.3% below its estimated fair value. The current EV-to-OCF is 1,676.18 and 15320.2% above the Drug Manufacturers industry median of 10.87. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current EV-to-OCF is 1,676.18 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:LGP has been successfully added to your 
